Skip to content
HowShorted

Zosano Pharma Corp short interest in 2020

In 2020, Zosano Pharma Corp's disclosed short interest ran from 13.08% of shares outstanding on 15 Jan 2020 to 6.70% on 31 Dec 2020, a change of -6.38 percentage points. The year's high was 19.15% on 28 Feb 2020 and its low 5.83% on 30 Sep 2020, averaging 9.61% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.58 days on 15 Jan 2020. Full history: Zosano Pharma Corp.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Zosano Pharma Corp in 2020

2020 in figures

Start of year
13.08% (15 Jan 2020)
End of year
6.70% (31 Dec 2020)
Change
-6.38 pp
High
19.15% (28 Feb 2020)
Low
5.83% (30 Sep 2020)
Average
9.61%
Highest days to cover
7.58 (15 Jan 2020)
SEC filings marked
9

Every report in 2020

Zosano Pharma Corp short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202013.08%7.58
31 Jan 202010.94%4.61
14 Feb 202015.59%1.00results (8-K)
28 Feb 202019.15%1.00
13 Mar 20208.81%1.0010-K filed, results (8-K)
31 Mar 20205.90%1.87
15 Apr 20208.45%1.71
30 Apr 20209.14%3.24
15 May 20209.62%3.1210-Q filed, results (8-K)
29 May 202011.08%3.30
15 Jun 202010.18%3.66
30 Jun 202010.45%6.01
15 Jul 202010.87%5.94
31 Jul 202011.02%1.63
14 Aug 20208.52%1.0010-Q filed, results (8-K)
31 Aug 20207.86%1.09
15 Sep 20209.95%1.19
30 Sep 20205.83%1.00
15 Oct 20207.93%1.00
30 Oct 20208.40%1.28
13 Nov 20207.69%1.0510-Q filed, results (8-K)
30 Nov 20206.75%2.08
15 Dec 20206.71%2.92
31 Dec 20206.70%2.94

See also: Zosano Pharma Corp's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.